Therapy-induced hypoxia attenuates enzalutamide response and promotes resistance in pre-clinical models of prostate cancer.

Pamela Maxwell, David Waugh, Melissa LaBonte Wilson*

*Corresponding author for this work

Research output: Contribution to conferenceAbstractpeer-review

Original languageEnglish
Publication statusPublished - 28 Nov 2017
EventEuropean Alliance for Personalised Medicine Conference : “Personalising your Health: A Global Imperative” - Belfast, United Kingdom
Duration: 25 Nov 201729 Nov 2017


ConferenceEuropean Alliance for Personalised Medicine Conference
Country/TerritoryUnited Kingdom

Cite this